Keith Bostian

Keith Bostian is a prominent executive in the life sciences sector, currently serving as the Chief Executive Officer of Kathera Bioscience Inc. since November 2019 and the CEO of the Institute For Life Science Entrepreneurship since June 2014. Bostian holds the position of Associate Provost for Science and Technology at Kean University and has acted as a Senior Consultant and Scientific Advisor for Kemin Industries since January 2013. Bostian's past leadership roles include Acting CEO at Prokaryotics, Inc., President and CEO of Vanta Bioscience and Amalyte Pharmaceuticals, and President of Kemin Pharma. Bostian also served as Chief Scientific Officer and Board Member at Mpex Pharmaceuticals, and as President and CEO of Iconix Pharmaceuticals. Bostian obtained a PhD in Biochemistry from the University of London and a BA in Chemistry and Biology from Augustana University.